Company: IXHL
Filing Date: 2025-04-17
Form Type: PRER14A
Source: 0001213900-25-033013
Chunk: 9

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-17
Form: PRER14A
Chunk 9
---
 A Warrants) shares of our common stock underlying the Series A Warrants, issued in connection with a private  
 placement and sale of our securities that was consummated on March 10, 2025 and certain provisions of the Series A Warrants (the “Issuance   
 Proposal”)                                                                                                                                   |

| ☐ | “FOR” the approval of an amendment to our                                                                                                   
 Amended and Restated Certificate of Incorporation to increase the total number of shares of common stock authorized for issuance thereunder 
 from 100,000,000 shares to 800,000,000 shares (the “Charter Amendment Proposal”);                                                           |

| ☐ | “FOR” the approval of an amendment to our                                                                                                 
 2023 Equity Incentive Plan (the “2023 Plan”) to (x) increase the number of shares authorized for the issuance of awards by                
 2,700,000 and (y) to incorporate an evergreen provision to increase the number of shares under the 2023 Plan in future years (the “Equity 
 Incentive Plan Proposal”);                                                                                                                |

<div align='center'>4</div>

| ☐ | “FOR” the approval of an amendment to our                                                                                                     
 Amended and Restated Certificate of Incorporation to effect a reverse stock split of our common stock by a ratio of not less than 1-for-2     
 and not more than 1-for-50 (the “Reverse Stock Split”), with the exact ratio to be set within this range by our board of                      
 directors in its sole discretion (without reducing the authorized number of shares of our common stock) and with our board of directors       
 able to elect to abandon such proposed amendment and not effect the Reverse Stock Split authorized by our stockholders in its sole discretion 
 (the “Reverse Stock Split Proposal”); and                                                                                                     |

| ☐ | “FOR” the approval of any postponement or                                                                                              
 adjournment of the Special Meeting, from time to time, if necessary to solicit additional proxies if there are not sufficient votes at 
 the time of the Special Meeting to adopt the proposals set forth above (the “Adjournment Proposal”).                                   |

If any other matter is presented at the Special
Meeting, your proxy provides that your shares will be voted by the proxy holder listed in the proxy in accordance with the proxy holder’s
best judgment. At the time this proxy statement was first made available, we knew of no matters that needed to be acted on at the Special